Natural Killer Cell Subsets and Their Functional Activity in Behçet’s Disease

References

• Ahern DJ, Brennan FM. 2011. The role of Natural killer cells in the pathogenesis of rheumatoid arthritis: Major contributors or essential homeostatic modulators? Immunol Lett, 136, 115–21.
   Web of Science ®Google Scholar
• Aktas E, Akdis M, Bilgic S, et al. 2005. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol, 140, 301–9.
   PubMed Web of Science ®Google Scholar
• Aktas E, Erten G, Kucuksezer UC, Deniz G. 2009. Natural killer cells: Versatile roles in autoimmune and infectious diseases. Expert Rev Clin Immunol, 5, 405–20.
   PubMed Web of Science ®Google Scholar
• Aktas E, Kucuksezer UC, Bilgic S, et al. 2009. Relationship between CD107a expression and cytotoxic activity. Cell Immunol, 254, 149–54.
   PubMed Web of Science ®Google Scholar
• Aktas Cetin E, Cosan F, Kucuksezer UC, et al. 2013. Behçet’s disease: Immunological relevance with arthritis of ankylosing spondylitis. Rheumatol Int, 33, 733–41.
   PubMed Web of Science ®Google Scholar
• Aktas Cetin E, Cosan F, Cefle A, Deniz G. 2014. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet’s disease. Mod Rheumatol, 24, 802–7.
   PubMed Web of Science ®Google Scholar
• Ben Ahmed M, Houman H, Miled M, et al. 2004. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet’s disease. Arthritis Rheum, 50, 2291–5.
   PubMed Web of Science ®Google Scholar
• Bhakta BB, Brennan P, James TE, et al. 1999. Behçet’s disease: Evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford), 38, 728–33.
   PubMed Web of Science ®Google Scholar
• Bottino C, Biassoni R, Millo R, et al. 2000. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum Immunol, 61, 1–6.
   PubMed Web of Science ®Google Scholar
• Bryceson YT, Long EO. 2008. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol, 20, 344–52.
   PubMed Web of Science ®Google Scholar
• Cella M, Fuchs A, Vermi W, et al. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature, 457, 722–5.
   PubMed Web of Science ®Google Scholar
• Cho S, Kim J, Cho SB, et al. 2014. Immunopathogenic characterization of cutaneous inflammation in Behçet’s disease. J Eur Acad Dermatol Venereol, 28, 51–7.
   PubMed Web of Science ®Google Scholar
• Claus M, Greil J, Watzl C. 2009. Comprehensive analysis of NK cell function in whole blood samples. J Immunol Methods, 341, 154–64.
   PubMed Web of Science ®Google Scholar
• Cooper MA, Caligiuri MA. 2004. Isolation and characterization of human natural killer cell subsets. Curr Protoc Immunol, 34. Chapter 7:Unit 7.
   PubMedGoogle Scholar
• Deniz G, Erten G, Kücüksezer UC, et al. 2008. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol, 180, 850–57.
   PubMed Web of Science ®Google Scholar
• Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, et al. 2001. Neutrophil activation in Behçet’s disease. Clin Exp Rheumatol, 19, S19–24.
   PubMed Web of Science ®Google Scholar
• Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG. 2002. The natural killer cell – friend or foe in autoimmune disease? Scand J Immunol, 55, 432–41.
   PubMed Web of Science ®Google Scholar
• Flodström-Tullberg M, Bryceson YT, Shi F-D, et al. 2009. Natural killer cells in human autoimmunity. Curr Opin Immunol, 21, 634–40.
   PubMed Web of Science ®Google Scholar
• Fogel LA, Yokoyama WM, French AR. 2013. Natural killer cells in human autoimmune disorders. Arthritis Res Ther, 15(4), 216.
   PubMed Web of Science ®Google Scholar
• Frassanito MA, Dammacco R, Cafforio P, Dammacco F. 1999. Th1 polarization of the immune response in Behçet’s disease: A putative pathogenetic role of interleukin-12. Arthritis Rheum, 42, 1967–74.
   PubMed Web of Science ®Google Scholar
• French AR, Yokoyama WM. 2004. Natural killer cells and autoimmunity. Arthritis Res Ther, 6, 8–14.
   PubMed Web of Science ®Google Scholar
• Giuliani M, Giron-Michel J, Negrini S, et al. 2008. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS One, 3, e2241.
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Ayed K, Hamza M, Touraine JL. 1988. Natural killer cells in Behçet’s disease. Clin Exp Immunol, 71, 126–31.
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Berraies A, Kaabachi W, et al. 2013. Pulmonary manifestations in Behçet disease: Impaired natural killer cells activity. Multidiscip Respir Med, 8, 29.
   PubMed Web of Science ®Google Scholar
• Henriques A, Teixeira L, Inês L, et al. 2013. NK cells dysfunction in systemic lupus erythematosus: Relation to disease activity. Clin Rheumatol, 32, 805–13.
   PubMed Web of Science ®Google Scholar
• Hudspeth K, Silva-Santos B, Mavilio D. 2013. Natural cytotoxicity receptors: Broader expression patterns and functions in innate and adaptive immune cells. Front Immunol, 4, 69.
   PubMed Web of Science ®Google Scholar
• International study group for Behcets disease: Criteria for diagnosis of Behcet’s disease. 1990. Lancet, 335, 1078–80.ü.
   Google Scholar
• Jamieson AM, Diefenbach A, McMahon CW, et al. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity, 17, 19–29.
   PubMed Web of Science ®Google Scholar
• Kaneko F, Takahashi Y, Muramatsu R, et al. 1985. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet’s disease. Br J Dermatol, 113, 313–8.
   PubMed Web of Science ®Google Scholar
• Kim GG, Donnenberg VS, Donnenberg AD, et al. 2007. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assay. J Immunol Methods, 325, 51–66.
   PubMed Web of Science ®Google Scholar
• Kucuksezer UC, Aktas-Cetin E, Bilgic-Gazioglu S, et al. 2015. Natural killer cells dominate a Th-1 polarized response in Behçet’s disease patients with uveitis. Clin Exp Rheumatol, 33(6 Suppl 94), 24–9.
   Web of Science ®Google Scholar
• Lanier LL. 2005. NK cell recognition. Annu Rev Immunol, 23, 225–74.
   PubMed Web of Science ®Google Scholar
• Lünemann A, Tackenberg B, DeAngelis T, et al. 2011. Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis. Int Immunol, 23, 139–48.
   PubMed Web of Science ®Google Scholar
• Neves FS, Spiller F. 2013. Possible mechanisms of neutrophil activation in Behçet’s disease. Int Immunopharmacol, 17, 1206–10.
   PubMed Web of Science ®Google Scholar
• Neves FS, Carrasco S, Goldenstein-Schainberg C, et al. 2009. Neutrophil hyperchemotaxis in Behçet’s disease: A possible role for monocytes orchestrating bacterial-induced innate immune responses. Clin Rheumatol, 28, 1403–10.
   PubMed Web of Science ®Google Scholar
• Onder M, Bozkurt M, Gürer MA, et al. 1994. Natural cellular cytotoxicity in Behçet’s disease. J Dermatol, 21, 239–43.
   PubMedGoogle Scholar
• Pandya AD, Al-Jaderi Z, Høglund RA, et al. 2011. Identification of human NK17/NK1 cells. PLoS One, 6, e26780.
   PubMed Web of Science ®Google Scholar
• Park YW, Kee SJ, Cho YN, et al. 2009. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum, 60, 1753–63.
   PubMed Web of Science ®Google Scholar
• Perricone R, Perricone C, De Carolis C, Shoenfeld Y. 2008. NK cells in autoimmunity: A two-edg’d weapon of the immune system. Autoimmun Rev, 7, 384–90.
   PubMed Web of Science ®Google Scholar
• Remmers EF, Cosan F, Kirino Y, et al. 2010. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet, 42, 698–702.
   PubMed Web of Science ®Google Scholar
• Sakly K, Lahmar R, Nefzi F, et al. 2014. Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet’s disease and association with HLA-B51 expression. Immunol Invest, 43, 463–78.
   PubMed Web of Science ®Google Scholar
• Schepis D, Gunnarsson I, Eloranta ML, et al. 2009. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology, 126, 140–6.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. 1992. Increased peripheral blood γδ+ T cells and natural killer cells in Behçet’s disease. J Rheumatol, 19, 588–92.
   PubMed Web of Science ®Google Scholar
• Thorén FB, Riise RE, Ousbäck J, et al. 2012. Human NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism. J Immunol, 188, 1668–74.
   PubMed Web of Science ®Google Scholar
• Türe-Özdemir F, Tulunay A, Elbasi MO, et al. 2013. Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet’s disease. Rheumatology (Oxford), 52, 800–5.
   PubMed Web of Science ®Google Scholar
• Vivier E, Nunès JA, Vély F. 2004. Natural killer cell signaling pathways. Science, 306, 1517–9.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Takahashi H, Satoh T, et al. 2010. Natural killer cells control a T-helper 1 response in patients with Behçet’s disease. Arthritis Res Ther, 12, R80.
   PubMed Web of Science ®Google Scholar